Since FSH primarily exerts its biological function through binding to the FSH receptor (FSHR), it suggests FSHR may be a potential therapeutic target for diabetes control in overweight or obese postmenopausal women [34]. This evidence concerns the gene BRD2 and diabetes mellitus.